Article Versions Notes

Arcidiacono D, Zaramella A, Fabris F, Sánchez-Rodríguez R, Nucci D, Fassan M, Nardi M, Benna C, Cristofori C, Morbin T, et al. Insulin/IGF-1 Signaling Is Downregulated in Barrett’s Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial. Nutrients. 2021; 13(10):3638. https://doi.org/10.3390/nu13103638

Arcidiacono, Diletta, Alice Zaramella, Federico Fabris, Ricardo Sánchez-Rodríguez, Daniele Nucci, Matteo Fassan, Mariateresa Nardi, Clara Benna, Chiara Cristofori, Tiziana Morbin, and et al. 2021. "Insulin/IGF-1 Signaling Is Downregulated in Barrett’s Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial" Nutrients 13, no. 10: 3638. https://doi.org/10.3390/nu13103638

Arcidiacono, D., Zaramella, A., Fabris, F., Sánchez-Rodríguez, R., Nucci, D., Fassan, M., Nardi, M., Benna, C., Cristofori, C., Morbin, T., Pucciarelli, S., Fantin, A., & Realdon, S. (2021). Insulin/IGF-1 Signaling Is Downregulated in Barrett’s Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial. Nutrients, 13(10), 3638. https://doi.org/10.3390/nu13103638